e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
Discovery and characterization of 4'-(2-furyl)-N-pyridin-3-yl-4, 5'-bipyrimidin-2'-amine (LAS38096), a potent, selective, and efficacious A2B adenosine receptor …
A novel series of N-heteroaryl 4'-(2-furyl)-4, 5'-bipyrimidin-2'-amines has been identified as potent and selective A2B adenosine receptor antagonists. In particular, compound 5 showed high affinity for the A2B receptor (K i= 17 nM), good selectivity (IC50: A1> 1000 nM, A2A> 2500 nM, A3> 1000 nM), displayed a favorable pharmacokinetic profile in preclinical species, and showed efficacy in functional in vitro models.